Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Humoral response to West Nile virus vaccination in alpacas and llamas.
Journal of the American Veterinary Medical Association    August 27, 2004   Volume 225, Issue 3 414-416 doi: 10.2460/javma.2004.225.414
Kutzler MA, Baker RJ, Mattson DE.To determine humoral responses to an equine West Nile virus (WNV) vaccine in healthy alpacas and llamas and compare responses in alpacas and llamas with responses in horses. Methods: Clinical trial. Methods: 28 alpacas, 56 llamas, and 16 horses. Methods: Horses received 2 vaccinations at 4-week intervals, and alpacas and llamas received 3 vaccinations at 3-week intervals. Fifty-five llamas received a fourth vaccination 3 weeks after the third. Blood samples were collected immediately prior to each vaccination, 3 weeks after the last vaccination for alpacas and llamas, and 4 weeks after the las...
Epidemiology of Trichinella infection in the horse: the risk from animal product feeding practices.
Veterinary parasitology    August 25, 2004   Volume 123, Issue 3-4 223-233 doi: 10.1016/j.vetpar.2004.06.008
Murrell KD, Djordjevic M, Cuperlovic K, Sofronic Lj, Savic M, Djordjevic M, Damjanovic S.A discovery in 2002 of a Trichinella spiralis-infected horse in Serbia offered an opportunity to conduct needed epidemiological studies on how horses, considered herbivores, acquire a meat-borne parasite. This enigma has persisted since the first human outbreaks from infected horse meat occurred in then 1970s. The trace back of the infected horse to a farm owner was carried out. Interviews and investigations on the farm led to the conclusion that the owner had fed the horse food waste in order to condition the horse prior to sale. Further investigations were then carried out to determine the f...
Isolation of methicillin-resistant Staphylococcus aureus from the environment in a veterinary teaching hospital.
Journal of veterinary internal medicine    August 24, 2004   Volume 18, Issue 4 468-470 doi: 10.1892/0891-6640(2004)182.0.co;2
Weese JS, DaCosta T, Button L, Goth K, Ethier M, Boehnke K.After recognition of a cluster of methicillin-resistant Staphylococcus aureus (MRSA) infection in horses and humans at the Ontario Veterinary College Veterinary Teaching Hospital, environmental contamination with MRSA was evaluated. A total of 260 environmental surfaces were sampled during periods when MRSA-infected horses were hospitalized, and MRSA was isolated from 25/260 sites (9.6%). The most commonly contaminated sites were stalls housing MRSA-positive horses, but other stalls, medical equipment, personal items, and equine restraint devices also were contaminated. The role of the environ...
Effect of dietary corn oil supplementation on equine gastric fluid acid, sodium, and prostaglandin E2 content before and during pentagastrin infusion.
Journal of veterinary internal medicine    August 24, 2004   Volume 18, Issue 4 545-549 doi: 10.1892/0891-6640(2004)182.0.co;2
Cargile JL, Burrow JA, Kim I, Cohen ND, Merritt AM.The effect of corn oil (approximately 60% [wt/vol] linoleic acid) dietary supplementation on various components of equine gastric secretion was studied by use of a repeated-measures experimental design. Four healthy adult ponies were surgically fitted with gastric cannulas. The ponies were then fed a free-choice hay diet for 5 weeks, which was followed by 5 weeks of the same diet supplemented with 45 mL of corn oil daily. Gastric contents were analyzed under basal and pentagastrin-stimulated conditions once weekly during the latter 2 weeks on each diet. Gastric contents were collected at 30-mi...
Prevention of ischaemia-induced small intestinal adhesions in foals.
Equine veterinary journal    July 16, 2004   Volume 36, Issue 5 370-375 doi: 10.2746/0425164044868431
Sullins KE, White NA, Lundin CS, Dabareiner R, Gaulin G.Treatments addressing variously theorised pathophysiological mechanisms of small intestinal adhesions have been reported. This study applied those classes of treatments to the most clinically relevant aetiology of post operative adhesions. Objective: Treatments addressing the pathophysiology of ischaemia-reperfusion induced adhesions would accordingly reduce the incidence of adhesions from this model. Methods: Four classes of treatments were administered for 72 h to 16 foals subjected to complete ischaemia followed by reperfusion to create peritoneal adhesions. These groups were: 1) FPG group-...
Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
Equine veterinary journal    July 16, 2004   Volume 36, Issue 5 447-451 doi: 10.2746/0425164044868332
Patel JR, Didlick S, Bateman H.Currently, there is no recommended immunoprophylaxis against febrile respiratory diseases due to equine herpesvirus-1 (EHV-1) and -4 (EHV-4) in horses below age 5-6 months. This is because of interference by maternally-derived antibody (MDA) of vaccines. Objective: Unweaned equine foals are an important reservoir of EHV-1 transmission; therefore, we experimentally assessed the efficacy of a live EHV-1 vaccine in foals age 1.4-3.5 months with MDA. Methods: Following vaccination and challenge, parameters assessed were virus shedding in nasal mucus, leucocyte-associated viraemia, circulating viru...
Equine viral vaccines: the past, present and future.
Veterinary research    July 9, 2004   Volume 35, Issue 4 425-443 doi: 10.1051/vetres:2004019
Minke JM, Audonnet JC, Fischer L.The increasing international movement of horses combined with the relaxation of veterinary regulations has resulted in an increased incidence of equine infectious diseases. Vaccination, along with management measures, has become the primary method for the effective control of these diseases. Traditionally modified live and inactivated vaccines have been used and these vaccines have proven to be very successful in preventing disease. However, there are a number of equine infectious diseases for which conventional technology has shown its limitations. The advent of recombinant technology has sti...
Current perspectives on control of equine influenza.
Veterinary research    July 9, 2004   Volume 35, Issue 4 411-423 doi: 10.1051/vetres:2004023
Daly JM, Newton JR, Mumford JA.Influenza A viruses of the H3N8 subtype are a major cause of respiratory disease in horses. Subclinical infection with virus shedding can occur in vaccinated horses, particularly where there is a mismatch between the vaccine strains and the virus strains circulating in the field. Such infections contribute to the spread of the disease. Rapid diagnostic techniques are available for detection of virus antigen and can be used as an aid in control programmes. Improvements have been made to methods of standardising inactivated virus vaccines, and a direct relationship between vaccine potency measur...
DNA vaccines–back in the saddle again?
Nature biotechnology    July 2, 2004   Volume 22, Issue 7 799-801 doi: 10.1038/nbt0704-799
Powell K.A promising new horse vaccine may reignite enthusiasm for DNA vaccine technology in designing prophylactics against infectious disease. Kendall Powell reports.
Certification of imported equine semen.
The Veterinary record    July 1, 2004   Volume 154, Issue 24 767 
Gibbens N.No abstract available
[Voorjaarsdagen (Spring Days) 2004: the horse].
Tijdschrift voor diergeneeskunde    June 24, 2004   Volume 129, Issue 11 372-374 
Reijerkerk E, Westermann C.No abstract available
Use of a topical disinfectant as part of a hoof care programme for horses with diseases of the hoof capsule.
The Veterinary record    June 17, 2004   Volume 154, Issue 21 647-652 doi: 10.1136/vr.154.21.647
Kempson SA, Robb R.Twenty-three horses with persistent hoof horn defects were treated topically with a hoof disinfectant as part of a hoof care programme for a year. The active ingredients of the disinfectant were a poloaximer-iodine complex, ethylenediamine dihydriodide, isopropyl alcohol and propylene glycol. Hoof trimmings were taken at the start of the study and every six weeks, and examined by scanning and transmission electron microscopy. At the beginning of the study all the horn samples contained large numbers of bacteria, and samples from eight of the horses also had fungal hyphae intermingled with the ...
Screening of the equine intestinal microflora for potential probiotic organisms.
Equine veterinary journal    May 28, 2004   Volume 36, Issue 4 351-355 doi: 10.2746/0425164044890616
Weese JS, Anderson ME, Lowe A, Penno R, da Costa TM, Button L, Goth KC.Probiotics have not been demonstrated to provide any beneficial health effects in horses, possibly because of improper selection of probiotic organisms. This study was designed to identify lactic acid bacteria of equine origin with predetermined beneficial properties which might make them useful as therapeutic probiotics. Objective: A small percentage of lactic acid bacteria that are native to the intestinal tract of horses possess properties that may be useful in the treatment and/or prevention of gastrointestinal disease in horses. Methods: Faecal samples were collected from healthy mature h...
Treatment and follow-up of clinical cyathostominosis in horses.
Journal of veterinary medicine. A, Physiology, pathology, clinical medicine    May 26, 2004   Volume 50, Issue 10 527-529 doi: 10.1111/j.1439-0442.2004.00586.x
Deprez P, Vercruysse J.The results of the treatment with moxidectin or ivermectin of 20 horses with clinical cyathostominosis were studied during a 3-week observation period. Both treatments were effective in completely eliminating larvae from the faeces within 1 or 2 weeks, but no significant improvement in body weight or clinical parameters could be demonstrated over the observation period. The poor short time results of the treatment support the need for an adequate prevention of cyathostominosis in horses.
The mystery of fungal infection in the guttural pouches.
Veterinary journal (London, England : 1997)    May 26, 2004   Volume 168, Issue 1 60-64 doi: 10.1016/S1090-0233(03)00108-4
Lepage OM, Perron MF, Cadoré JL.Advances in the understanding of guttural pouch physiology and novel therapeutic approaches to mycotic infections in the horse are reviewed. It is suggested that the guttural pouches may contribute to the regulation of arterial blood temperature, cooling the circulation to the brain to below body temperature. Aspergillus spp. is the major organism found in a guttural pouch affected with mycosis but it is unclear why this agent becomes aggressive. Conventional therapy aims to prevent fatal haemorrhage and to treat any neurological lesions but it is desirable to try to prevent the disease. A tec...
Evaluation of immune responses in horses immunized using a killed Sarcocystis neurona vaccine.
Veterinary therapeutics : research in applied veterinary medicine    May 20, 2004   Volume 5, Issue 1 34-42 
Marsh AE, Lakritz J, Johnson PJ, Miller MA, Chiang YW, Chu HJ.Clinically normal horses developed cellular immunity to Sarcocystis neurona following IM vaccination with a commercial killed S. neurona vaccine, as indicated by the development of measurable anti-S. neurona IgG antibodies and additional intradermal skin testing. Large-scale independent assessments of the vaccine's performance and safety are in progress under field conditions. The next step in the evaluation of this vaccine would be to attempt experimental challenge after a reproducible reliable equine model of S. neurona encephalitis has been established that allows for reisolation of the pat...
Cushing’s syndromes, insulin resistance and endocrinopathic laminitis.
Equine veterinary journal    May 19, 2004   Volume 36, Issue 3 194-198 doi: 10.2746/0425164044877279
Johnson PJ, Messer NT, Ganjam VK.No abstract available
Equine laminitis: cryotherapy reduces the severity of the acute lesion.
Equine veterinary journal    May 19, 2004   Volume 36, Issue 3 255-260 doi: 10.2746/0425164044877107
van Eps AW, Pollitt CC.The hypometabolic and vasoconstrictive effects of cryotherapy could prevent the development of laminitis. Objective: To use distal limb cryotherapy to prevent laminitis induced by alimentary carbohydrate overload. Methods: Laminitis was induced in 6 Standardbred horses that had one front limb continuously cooled in an ice/water mixture. Lameness evaluation, blinded lamellar histological grading and analysis for lamellar matrix metalloproteinase-2 (MMP-2) mRNA expression were used to evaluate the severity of laminitis. Results: Cryotherapy was well tolerated and effective in cooling the feet. I...
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Archives of virology. Supplementum    May 4, 2004   Issue 18 221-230 doi: 10.1007/978-3-7091-0572-6_20
Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B.An ALVAC (canarypoxvirus)-based recombinant (vCP2017) expressing the prM and E genes derived from a 1999 New York isolate of West Nile virus (WNV) was constructed and assessed for its protective efficacy in horses in two different experiments. In the first trial, a dose titration study was conducted to evaluate both serum neutralising antibody responses to WNV and duration of immunity. In the second trial the onset of protection was determined. Twenty-eight adult horses received two doses of vCP2017 administered intramuscularly at 5-week intervals and sixteen horses comprised age-matched non-v...
Equine hyperlipaemia: a review.
Australian veterinary journal    April 20, 2004   Volume 82, Issue 3 136-142 doi: 10.1111/j.1751-0813.2004.tb12636.x
Hughes KJ, Hodgson DR, Dart AJ.No abstract available
Exotic Animal Diseases Bulletin.
Australian veterinary journal    April 20, 2004   Volume 82, Issue 1-2 16-17 doi: 10.1111/j.1751-0813.2004.tb14623.x
No abstract available
Design and organization of an equine intensive care unit.
The Veterinary clinics of North America. Equine practice    April 6, 2004   Volume 20, Issue 1 1-10 doi: 10.1016/j.cveq.2003.11.004
Hardy J.Careful planning and design of a new ICU are warranted to maximize use of the facility, minimize the risk of hospital-acquired infection, and improve overall patient outcome. In addition, personnel satisfaction improves with an improved work environment. A functional equine ICU is also tailored to the geographic area, local needs of the practice, and anticipated investment.
Prospects for vaccination against equine grass sickness.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 186-191 doi: 10.2746/0425164044868710
Hedderson EJ, Newton JR.Their is both historical and modern scientific evidence to support the hypothesis that equine grass sickness (EC'S) is caused by a toxico-infectious form of botulism involving a Clostridium botulism type C toxin 1114 is produced locally within the gastrointestinal tract of affected horses (Toc her et al. 1923: Tneher 1924: Hunter a aL 1999: Hunter and anion 2001: McCarthy 2002: McCarthy a aL 201)4a1. This report concerns a meeting convened to review the current state of knowledge and possible strategies for vaccination against EGS. including historical. clinical and pathological aspects of the...
Why are certain premises at increased risk of equine grass sickness? A matched case-control study.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 130-134 doi: 10.2746/0425164044868594
McCarthy HE, French NP, Edwards GB, Miller K, Proudman CJ.Equine grass sickness (EGS) occurs repeatedly on certain premises over time. Few studies have sought, or identified, the determinants of this phenomenon in order to inform advice on disease prevention strategies. Objective: Premises-level risk factors are important determinants of whether EGS occurs. Methods: A matched case-control study was undertaken. Sixty premises giving rise to one or more histologically confirmed case of EGS and 120 time-matched control premises were sampled. Data were collected on pasture management, soil nutrient content, pasture nutrient content and local weather cond...
Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 123-129 
McCarthy HE, French NP, Edwards GB, Poxton IR, Kelly DF, Payne-Johnson CE, Miller K, Proudman CJ.Equine grass sickness is a high mortality disease which, despite many years of investigation, is of unknown aetiology. Recent findings indicating that the disease is associated with Clostridium botulinum require support from an epidemiological study that recognises and controls for potential confounders, e.g. age, time of year and premises. Objective: EGS is associated with low antibody levels to C. botulinum antigens. Methods: A matched case-control study was conducted. Data were collected from 66 histologically confirmed cases of EGS and 132 premises-matched control horses. The probability o...
Descriptive epidemiology of fractures occurring in British Thoroughbred racehorses in training.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 167-173 doi: 10.2746/0425164044868684
Verheyen KL, Wood JL.Musculoskeletal injury is the major cause of days lost from training and wastage in Thoroughbred racehorses. Little scientific information is available on the majority of injuries occurring in training. Objective: To estimate the incidence of fractures in British racehorses in training and describe the occurrence of different fracture types and bones involved. Methods: Thirteen UK racehorse trainers participated in a prospective study, providing data on horses in their care for 2 years. Details on horses, their daily exercise and fracture occurrence were recorded. Results: A total of 1178 hors...
An epidemiological study of risk factors associated with the recurrence of equine grass sickness (dysautonomia) on previously affected premises.
Equine veterinary journal    March 25, 2004   Volume 36, Issue 2 105-112 doi: 10.2746/0425164044868639
Newton JR, Hedderson EJ, Adams VJ, McGorum BC, Proudman CJ, Wood JL.The reasons why equine grass sickness (EGS) recurs on premises are unknown and, consequently, practical methods for reducing the risk of recurrence are not available. Objective: To identify risk factors associated with recurrence of EGS on premises and to gain possible insights into the pathogenesis of the disease. Methods: Data on disease history and risk factors were collected by postal questionnaire from premises with EGS cases between 1st January 1997 and 31st December 2001. Data on variation in rates of recurrence of EGS for different risk factors were analysed using Poisson regression an...
Effects of ketanserin on hypergranulation tissue formation, infection, and healing of equine lower limb wounds.
The Canadian veterinary journal = La revue veterinaire canadienne    March 18, 2004   Volume 45, Issue 2 144-149 
Engelen M, Besche B, Lefay MP, Hare J, Vlaminck K.The objective of this multicentre, randomized, controlled field study was to determine the efficacy of ketanserin gel in preventing exuberant granulation tissue formation (hypergranulation) and infection in equine lower limb wounds. Horses and ponies (n = 481) with naturally occurring wounds were randomized to either topical treatment with ketanserin gel (n = 242) or a positive control (Belgium, Germany: ethacridin lactate solution, n = 120; France, United Kingdom: malic, benzoic, and salicylic acid [MBS] cream, n = 119). Treatment continued until the wound healed (success), formed hypergranul...
Eastern tent caterpillars (Malacosoma americanum) cause mare reproductive loss syndrome.
Journal of insect physiology    March 17, 2004   Volume 50, Issue 2-3 185-193 doi: 10.1016/j.jinsphys.2003.11.008
Webb BA, Barney WE, Dahlman DL, DeBorde SN, Weer C, Williams NM, Donahue JM, McDowell KJ.A new equine abortigenic disease, mare reproductive loss syndrome (MRLS), was recognized and significantly impacted the Ohio Valley in the springs of 2001 and 2002. MRLS caused approximately 330 million US dollars in losses in 2001. An epidemiological investigation of MRLS associated occurrence of the disease with exposure to eastern tent caterpillars (M. americanum). This work investigates the epidemiological association between M. americanum and MRLS to determine if this association was correlative or causative. A pilot study and simulated exposure to M. americanum and their excreta on pastu...
The current challenges of dourine: difficulties in differentiating Trypanosoma equiperdum within the subgenus Trypanozoon.
Revue scientifique et technique (International Office of Epizootics)    March 10, 2004   Volume 22, Issue 3 1087-1096 doi: 10.20506/rst.22.3.1460
Zablotskij VT, Georgiu C, de Waal T, Clausen PH, Claes F, Touratier L.During its 20th annual meeting in Paris in May 1999, the OIE (World organisation for animal health) Ad Hoc Group on Non-Tsetse Transmitted Animal Trypanosomoses expressed the following concerns about dourine: the discrepancies in some of the results of the complement fixation test (CFT), which is the only international diagnostic test officially recognised by the International Organisation for the Transportation of Equidae; the persistence of suspected cases of dourine in some Asian, European and African countries; the impossibility of differentiating Trypanosoma equiperdum from Trypanosoma ev...
1 65 66 67 68 69 119